MEDICAMEN BIOTECH LTD. - Statement For Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended September 30, 2022

Pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/ 162/2019 dated December 24, 2019; please find enclosed herewith Statement of deviation(s) or variation(s) of funds raised through preferential issue by the Company in the specified format, for the quarter ended September 30, 2022. The same has been reviewed by the Audit Committee of the Company on 11.11.2022